trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Fibromatosis, Aggressive D018222 2 associated lipids
Rhabdomyosarcoma, Alveolar D018232 2 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Carcinoma, Papillary, Follicular D018265 1 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Cystadenocarcinoma, Mucinous D018282 1 associated lipids
Cystadenocarcinoma, Serous D018284 2 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Soriano FX et al. SMRT-mediated co-shuttling enables export of class IIa HDACs independent of their CaM kinase phosphorylation sites. 2013 J. Neurochem. pmid:23083128
Liu RF et al. Down-regulation of miR-517a and miR-517c promotes proliferation of hepatocellular carcinoma cells via targeting Pyk2. 2013 Cancer Lett. pmid:23142219
Chachadi VB et al. Prostatic cell-specific regulation of the synthesis of MUC1-associated sialyl Lewis a. 2013 PLoS ONE pmid:23451223
Kim YJ et al. HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade. 2013 Oncogene pmid:23435418
Day JA and Cohen SM Investigating the selectivity of metalloenzyme inhibitors. 2013 J. Med. Chem. pmid:24074025
Zhang Z et al. Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells. 2013 Cell Death Dis pmid:23681228
Kannan V et al. Histone deacetylase inhibitors suppress immune activation in primary mouse microglia. 2013 J. Neurosci. Res. pmid:23686642
Johnson D and Walmsley R Histone-deacetylase inhibitors produce positive results in the GADD45a-GFP GreenScreen HC assay. 2013 Mutat. Res. pmid:23340162
Zhou G et al. HSV carrying WT REST establishes latency but reactivates only if the synthesis of REST is suppressed. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23341636
Tang X et al. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer. 2012-2013 Cancer Biomark pmid:23321465
Hou W et al. Hypoxia-induced deacetylation is required for tetraploid differentiation in response to testicular ischemia-reperfusion (IR) injury. 2012 Nov-Dec J. Androl. pmid:22556385
Darlyuk-Saadon I et al. The bZIP repressor proteins, c-Jun dimerization protein 2 and activating transcription factor 3, recruit multiple HDAC members to the ATF3 promoter. 2012 Nov-Dec Biochim. Biophys. Acta pmid:22989952
Guo X et al. Histone deacetylase inhibitors promote mice corneal allograft survival through alteration of CD4+ effector T cells and induction of Foxp3+ regulatory T cells. 2012 May-Jun Cell. Immunol. pmid:22776176
Mehdi O et al. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA). 2012 Mar-Apr Pancreatology pmid:22487525
Wu TC et al. Genistein enhances the effect of trichostatin A on inhibition of A549 cell growth by increasing expression of TNF receptor-1. 2012 Toxicol. Appl. Pharmacol. pmid:22626855
Kim YS et al. Histone deacetylase is required for the activation of Wnt/β-catenin signaling crucial for heart valve formation in zebrafish embryos. 2012 Biochem. Biophys. Res. Commun. pmid:22634317
Reddy P Editorial: HDAC inhibition begets more MDSCs. 2012 J. Leukoc. Biol. pmid:22547132
Srirattana K et al. Full-term development of gaur-bovine interspecies somatic cell nuclear transfer embryos: effect of trichostatin A treatment. 2012 Cell Reprogram pmid:22578161
Truong M et al. Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence. 2012 Br. J. Cancer pmid:22596233
Hsu DW et al. Dynamic acetylation of lysine-4-trimethylated histone H3 and H3 variant biology in a simple multicellular eukaryote. 2012 Nucleic Acids Res. pmid:22600736
Viñuelas J et al. Towards experimental manipulation of stochasticity in gene expression. 2012 Prog. Biophys. Mol. Biol. pmid:22609563
Londhe P et al. CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells. 2012 Int. J. Cancer pmid:21989738
Anh TD et al. The histone deacetylase inhibitor, Trichostatin A, induces G2/M phase arrest and apoptosis in YD-10B oral squamous carcinoma cells. 2012 Oncol. Rep. pmid:21993600
Gillespie J et al. Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients. 2012 Arthritis Rheum. pmid:21952924
Grabiec AM et al. Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay. 2012 Ann. Rheum. Dis. pmid:21953341
Maroni P et al. Chemical and genetic blockade of HDACs enhances osteogenic differentiation of human adipose tissue-derived stem cells by oppositely affecting osteogenic and adipogenic transcription factors. 2012 Biochem. Biophys. Res. Commun. pmid:23085045
Icardi L et al. Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2. 2012 FASEB J. pmid:21957129
Dar RD et al. Transcriptional burst frequency and burst size are equally modulated across the human genome. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:23064634
Yang Q et al. Pulmonary artery smooth muscle cell proliferation and migration in fetal lambs acclimatized to high-altitude long-term hypoxia: role of histone acetylation. 2012 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:23043075
Balsas P et al. Bortezomib resistance in a myeloma cell line is associated to PSMβ5 overexpression and polyploidy. 2012 Leuk. Res. pmid:21978467
Fan H et al. Sulforaphane causes a major epigenetic repression of myostatin in porcine satellite cells. 2012 Epigenetics pmid:23092945
Deckmann K et al. Dimethylcelecoxib induces an inhibitory complex consisting of HDAC1/NF-κB(p65)RelA leading to transcriptional downregulation of mPGES-1 and EGR1. 2012 Cell. Signal. pmid:21983014
Hoque MA et al. Cyclic tetrapeptides with thioacetate tails or intramolecular disulfide bridge as potent inhibitors of histone deacetylases. 2012 Bioorg. Med. Chem. Lett. pmid:23021104
Zhang L et al. Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts. 2012 J. Biol. Chem. pmid:23024362
Merschbaecher K et al. Acetylation-mediated suppression of transcription-independent memory: bidirectional modulation of memory by acetylation. 2012 PLoS ONE pmid:23028801
Zhao ZN et al. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC. 2012 PLoS ONE pmid:23028803
Banik D et al. Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity. 2012 PLoS ONE pmid:23028998
Duncan HF et al. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells. 2012 J Endod pmid:22341071
Kohda T et al. Gene expression profile normalization in cloned mice by trichostatin A treatment. 2012 Cell Reprogram pmid:22257163
Drzewiecka H and Jagodzinski PP Trichostatin A reduced phospholipase C gamma-1 transcript and protein contents in MCF-7 breast cancer cells. 2012 Biomed. Pharmacother. pmid:22257695
Shah S et al. Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression. 2012 Cancer Res. pmid:22258452
Cho JS et al. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts. 2012 Clin. Exp. Allergy pmid:22239687
Börner C et al. Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2'-deoxycytidine. 2012 Neuroimmunomodulation pmid:22262103
Francisco R et al. Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells. 2012 Cancer Lett. pmid:22186300
Wang HF et al. Transcription levels of sirtuin family in neural stem cells and brain tissues of adult mice. 2012 Cell. Mol. Biol. (Noisy-le-grand) pmid:22992439
Ma J et al. Coxsackievirus and adenovirus receptor promotes antitumor activity of oncolytic adenovirus H101 in esophageal cancer. 2012 Int. J. Mol. Med. pmid:22992863
Shi YL et al. Histone deacetylases inhibitor Trichostatin A ameliorates DNFB-induced allergic contact dermatitis and reduces epidermal Langerhans cells in mice. 2012 J. Dermatol. Sci. pmid:22999682
Tomosugi M et al. Retinoblastoma gene-independent G1 phase arrest by flavone, phosphatidylinositol 3-kinase inhibitor, and histone deacetylase inhibitor. 2012 Cancer Sci. pmid:22957647
Chang J et al. Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide. 2012 Br. J. Cancer pmid:22158273
Calfa G et al. HDAC activity is required for BDNF to increase quantal neurotransmitter release and dendritic spine density in CA1 pyramidal neurons. 2012 Hippocampus pmid:22161912
Horvat T et al. Epigenetic modulation of the HeLa cell membrane N-glycome. 2012 Biochim. Biophys. Acta pmid:22192783
Shen YC et al. The cytokine macrophage migration inhibitory factor (MIF) acts as a neurotrophin in the developing inner ear of the zebrafish, Danio rerio. 2012 Dev. Biol. pmid:22210003
Zhang CZ et al. Interaction between ZBP-89 and p53 mutants and its contribution to effects of HDACi on hepatocellular carcinoma. 2012 Cell Cycle pmid:22214764
Zhai FX et al. RUNX3 is involved in caspase-3-dependent apoptosis induced by a combination of 5-aza-CdR and TSA in leukaemia cell lines. 2012 J. Cancer Res. Clin. Oncol. pmid:22179198
Sancho-Pelluz J and Paquet-Durand F HDAC inhibition prevents Rd1 mouse photoreceptor degeneration. 2012 Adv. Exp. Med. Biol. pmid:22183322
Chen H et al. LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma. 2012 Cancer Lett. pmid:22743615
Vadnal J et al. Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer's disease. 2012 Exp Brain Res pmid:22811216
Lin KT et al. HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapy. 2012 Clin. Cancer Res. pmid:22811583
He Q et al. Characterization of an apical ceramide-enriched compartment regulating ciliogenesis. 2012 Mol. Biol. Cell pmid:22718902
Cogdill AP et al. Targeting the MAGE A3 antigen in pancreatic cancer. 2012 Surgery pmid:22770803
Tu Z et al. The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor β expression. 2012 Mol. Cell. Biochem. pmid:22476901
Halsall J et al. Genes are often sheltered from the global histone hyperacetylation induced by HDAC inhibitors. 2012 PLoS ONE pmid:22479401
Huang D et al. A novel series of l-2-benzyloxycarbonylamino-8-(2-pyridyl)-disulfidyloctanoic acid derivatives as histone deacetylase inhibitors: design, synthesis and molecular modeling study. 2012 Eur J Med Chem pmid:22465091
Chuma M et al. Hairless modulates ligand-dependent activation of the vitamin D receptor-retinoid X receptor heterodimer. 2012 Biol. Pharm. Bull. pmid:22466564
Li J et al. Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. 2012 Nat. Med. pmid:22466704
Majumdar G et al. Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cells. 2012 BMC Genomics pmid:23249388
Sangalli JR et al. Treatment of nuclear-donor cells or cloned zygotes with chromatin-modifying agents increases histone acetylation but does not improve full-term development of cloned cattle. 2012 Cell Reprogram pmid:22468998
Zhang S et al. [Effect of trichostatin A and paclitaxel on the growth and apoptosis of lung adenocarcinoma cell lines]. 2012 Zhonghua Zhong Liu Za Zhi pmid:22967465
Yamamura N and Kishimoto T Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma. 2012 Exp. Mol. Pathol. pmid:22472323
Zhang HN et al. Endogenous glucocorticoids inhibit myocardial inflammation induced by lipopolysaccharide: involvement of regulation of histone deacetylation. 2012 J. Cardiovasc. Pharmacol. pmid:22472906
Qin ZX et al. [Effect of TSA and VPA treatment on long-tailed macaque (Macaca fascicularis)-pig interspecies somatic cell nuclear transfer]. 2012 Yi Chuan pmid:22425953
Zhou X et al. Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells. 2012 Biochem. Biophys. Res. Commun. pmid:22425986
Fleiss B et al. Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury. 2012 J Neuroinflammation pmid:22512781
Glait-Santar C et al. Expression pattern of SVEP1 alternatively-spliced forms. 2012 Gene pmid:22659106
Park J et al. ARD1 binding to RIP1 mediates doxorubicin-induced NF-κB activation. 2012 Biochem. Biophys. Res. Commun. pmid:22580278
Yin Z et al. Position effect variegation and epigenetic modification of a transgene in a pig model. 2012 Genet. Mol. Res. pmid:22370938
Zhu K et al. Expression characterization and the promoter activity analysis of zebrafish hdac4. 2012 Fish Physiol. Biochem. pmid:21773810
Halldórsdóttir AM et al. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia. 2012 Am. J. Hematol. pmid:22374828
Schnichels S et al. Trichostatin A induces cell death at the concentration recommended to differentiate the RGC-5 cell line. 2012 Neurochem. Int. pmid:22391323
Chan JN et al. Target identification by chromatographic co-elution: monitoring of drug-protein interactions without immobilization or chemical derivatization. 2012 Mol. Cell Proteomics pmid:22357554
Rehni AK et al. Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome. 2012 Naunyn Schmiedebergs Arch. Pharmacol. pmid:22362134
Ikehata M et al. Different involvement of DNA methylation and histone deacetylation in the expression of solute-carrier transporters in 4 colon cancer cell lines. 2012 Biol. Pharm. Bull. pmid:22382314
Andrews KT et al. Comparative gene expression profiling of P. falciparum malaria parasites exposed to three different histone deacetylase inhibitors. 2012 PLoS ONE pmid:22384084
Zhu S et al. TSA-induced JMJD2B downregulation is associated with cyclin B1-dependent survivin degradation and apoptosis in LNCap cells. 2012 J. Cell. Biochem. pmid:22388778
Usui T et al. HDAC4 mediates development of hypertension via vascular inflammation in spontaneous hypertensive rats. 2012 Am. J. Physiol. Heart Circ. Physiol. pmid:22389387
Wang H et al. Different effects of histone deacetylase inhibitors nicotinamide and trichostatin A (TSA) in C17.2 neural stem cells. 2012 J Neural Transm pmid:22407380
Yang PM et al. CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1. 2012 Epigenetics pmid:22419072
Li L et al. Regulation of histone acetylation by NDRG2 in glioma cells. 2012 J. Neurooncol. pmid:21912936
Li L et al. Use of mouse hematopoietic stem and progenitor cells to treat acute kidney injury. 2012 Am. J. Physiol. Renal Physiol. pmid:21937606
Jee BC et al. Effect of trichostatin A on fertilization and embryo development during extended culture of mouse oocyte. 2012 Zygote pmid:21269543
Sustáčková G et al. Acetylation-dependent nuclear arrangement and recruitment of BMI1 protein to UV-damaged chromatin. 2012 J. Cell. Physiol. pmid:21732356
Wang C et al. Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats. 2012 Diabetes Metab. Res. Rev. pmid:22228707
Zhang QC et al. Histone deacetylase inhibitor trichostatin A enhances anti-tumor effects of docetaxel or erlotinib in A549 cell line. 2012 Asian Pac. J. Cancer Prev. pmid:22994780
Nepelska M et al. Butyrate produced by commensal bacteria potentiates phorbol esters induced AP-1 response in human intestinal epithelial cells. 2012 PLoS ONE pmid:23300800
Gupta K et al. Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanisms. 2012 PLoS ONE pmid:23285096
He M and Guo Q [Cerebral protection of Trichostatin A preconditioning in rats with middle cerebral artery occlusion and the relationship between Trichostatin A and IL-1β]. 2012 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:22561570
Catalano MG et al. Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells. 2012 J. Clin. Endocrinol. Metab. pmid:22563106
Yu L et al. Trichostatin A ameliorates myocardial ischemia/reperfusion injury through inhibition of endoplasmic reticulum stress-induced apoptosis. 2012 Arch. Med. Res. pmid:22564421
Bobkov DE et al. [Isolation of tropomyosin particles from the cytosol of cultured cells and their protein composition analysis]. 2012 Tsitologiia pmid:22567898
Li Q and Chen H Silencing of Wnt5a during colon cancer metastasis involves histone modifications. 2012 Epigenetics pmid:22522911